-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA ANNOUNCES TOPLINE RESULTS IN PHASE 2 SIGNAL DETECTION STUDY FOR HLP004 IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

Reuters·03/05/2026 12:30:01

Please log in to view news